Containment Genomics Packaging Sales 
Pharmaceutical Technology
DECEMBER 9, 2022
In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.
The Pharma Data
AUGUST 6, 2020
NEW YORK–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance. chairman and chief executive officer, Bristol Myers Squibb. In May, the company announced the U.S.
Expert insights. Personalized for you.
130 
Let's personalize your content